Compare DexCom, Inc. (DXCM) vs Toyota Motor Corp (TM) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Toyota Motor (TM) trades at $179.34, up 1.77% today, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 9.69 and consistent earnings beats, including Q1 2026 EPS of $4.00 versus $3.11 expected. Recent news highlights a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling growth commitment.

TM presents a value opportunity with attractive valuation ratios and solid profitability, but faces risks from competitive pressures and fluctuating net income margins. Analyst consensus is mixed with 37.5% buy ratings, indicating cautious optimism. The stock's outlook hinges on successful execution of US manufacturing investments and hybrid vehicle demand amid economic uncertainties.